We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Safety of combining biologics in severe asthma: Asthma‐related and unrelated combinations.
- Authors
Lommatzsch, Marek; Suhling, Hendrik; Korn, Stephanie; Bergmann, Karl‐Christian; Schreiber, Jens; Bahmer, Thomas; Rabe, Klaus F.; Buhl, Roland; Virchow, Johann Christian; Milger, Katrin
- Abstract
Monotherapies with antibodies approved for severe asthma treatment were reported to be safe, with side effects close to placebo1. The other 10 patients received one biologic for asthma treatment and another (not approved for asthma treatment) for an unrelated disease (Group B, Table 2). Safety of combining biologics in severe asthma: Asthma-related and unrelated combinations.
- Subjects
ASTHMA; BIOLOGICALS; INFLAMMATORY bowel diseases; NASAL polyps; ASTHMATICS; CROHN'S disease; WHEEZE
- Publication
Allergy, 2022, Vol 77, Issue 9, p2839
- ISSN
0105-4538
- Publication type
Article
- DOI
10.1111/all.15379